← Leaderboards
Stephen Jay Freedland
Cedars-Sinai Medical Center
$7,874,405
Attributed
$16,220,566
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,559,935 · 8
CDC$5,454,632 · 2
By mechanism
R01$8,227,203 · 4
U01$5,454,632 · 2
U2C$1,794,001 · 1
T32$987,574 · 1
K24$877,380 · 1
K12$673,777 · 1
Top collaborators
- Jennifer Tash Anger8 shared
- Michael R Freeman8 shared
- Jayoung Kim6 shared
- Neil A Bhowmick5 shared
- Tanya Dorff5 shared
- Pao-Hwa Lin5 shared
- Salvatore V Pizzo5 shared
- Tomas Ganz4 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Pao-Hwa Lin$758,037
- Jethro Hu$851,674
- Francesca Demichelis$421,824
- Isla Pearl Garraway$1,077,887
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateMalignant NeoplasmsTumorSignal TransductionFutureGrowthInsulinDietFatty Acid Glycerol EstersAffectPreventResistanceTumor ProgressionMorbidity - Disease RateClinical TrialsBody WeightPre-ClinicalCarbohydratesTranscriptomicsHigh RiskToxic EffectPathway InteractionsProgramsCancer Therapy
Grant awards (45)
RFA-DP-24-031: Longitudinal Follow-up of a Nationwide Multiethnic Cohort of Veterans and Non-Veterans with Interstitial Cystitis$830,000
U01 · FY2025 · DP
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes$684,131
R01 · FY2025 · CA · contact PI
Racial Difference in Prostate Cancer$460,263
R01 · FY2025 · CA
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2025 · DK
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment$268,951
R01 · FY2025 · CA
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes$102,955
R01 · FY2025 · CA · contact PI
RFA-DP-24-031: Longitudinal Follow-up of a Nationwide Multiethnic Cohort of Veterans and Non-Veterans with Interstitial Cystitis$830,000
U01 · FY2024 · DP
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment$695,258
R01 · FY2024 · CA
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes$644,974
R01 · FY2024 · CA · contact PI
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$414,001
U2C · FY2024 · DK
A Comparative Study of Risk Factors for Men with and without Prostate Cancer at the VA Medical Center in Durham$119,705
R01 · FY2024 · CA · contact PI
A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment$739,138
R01 · FY2023 · CA
Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes$722,345
R01 · FY2023 · CA · contact PI
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2023 · DK
A multidisciplinary training program in prostate cancer$319,057
T32 · FY2023 · CA
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology$460,000
U2C · FY2022 · DK
Racial Differences in Prostate Cancer Molecular Subtyping$392,306
R01 · FY2022 · CA
A multidisciplinary training program in prostate cancer$310,214
T32 · FY2022 · CA
Racial Differences in Prostate Cancer Molecular Subtyping$42,495
R01 · FY2022 · CA
Racial Differences in Prostate Cancer Molecular Subtyping$400,313
R01 · FY2021 · CA
A multidisciplinary training program in prostate cancer$145,562
T32 · FY2021 · CA
Racial Differences in Prostate Cancer Molecular Subtyping$85,038
R01 · FY2021 · CA
Racial Differences in Prostate Cancer Molecular Subtyping$550,313
R01 · FY2020 · CA
A multidisciplinary training program in prostate cancer$145,122
T32 · FY2020 · CA
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA Cohort$830,000
U01 · FY2019 · DP · contact PI
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA Cohort$720,000
U01 · FY2019 · DP · contact PI
Racial Differences in Prostate Cancer Molecular Subtyping$388,303
R01 · FY2019 · CA
A multidisciplinary training program in prostate cancer$67,619
T32 · FY2019 · CA
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA Cohort$599,995
U01 · FY2018 · DP · contact PI
Racial Differences in Prostate Cancer Molecular Subtyping$400,313
R01 · FY2018 · CA
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA Cohort$599,990
U01 · FY2017 · DP · contact PI
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA Cohort$600,000
U01 · FY2016 · DP · contact PI
Midcareer Investigator Award$175,476
K24 · FY2016 · CA · contact PI
The Epidemiology of Interstitial Cystitis in a Nationwide Multiethnic VA Cohort$444,647
U01 · FY2015 · DP · contact PI
Midcareer Investigator Award$175,476
K24 · FY2015 · CA · contact PI
Midcareer Investigator Award$175,476
K24 · FY2014 · CA · contact PI
Duke KURe Program$474,577
K12 · FY2013 · DK · contact PI
Duke KURe Program$199,200
K12 · FY2013 · DK · contact PI
Midcareer Investigator Award$175,476
K24 · FY2013 · CA · contact PI
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$300,504
R01 · FY2012 · CA · contact PI
Midcareer Investigator Award$175,476
K24 · FY2012 · CA · contact PI
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$300,504
R01 · FY2011 · CA · contact PI
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$309,798
R01 · FY2010 · CA · contact PI
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$309,798
R01 · FY2009 · CA · contact PI
Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression$309,798
R01 · FY2008 · CA · contact PI